After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against coronavirus (Covid-19) infection, the central government on Friday revised the advisory on the use of hydroxychloroquine as prophylactic for Covid-19 infection, expanding the use of the medicine for asymptomatic healthcare and frontline workers deployed in non-Covid and Covid-19 areas. The revised advisory issued by the Indian Council of Medical Research (ICMR) recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-Covid-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities. However, the council cautioned that the intake of the medicine should not instill a sense of false security.

After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against coronavirus (Covid-19) infection, the central government on Friday revised the advisory on the use of hydroxychloroquine as prophylactic for Covid-19 infection, expanding the use of the medicine for asymptomatic healthcare and frontline workers deployed in non-Covid and Covid-19 areas. The revised advisory issued by the Indian Council of Medical Research (ICMR) recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-Covid-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities. However, the council cautioned that the intake of the medicine should not instill a sense of false security.